XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current Assets:    
Cash and cash equivalents $ 199,252 $ 217,666
Restricted cash 525 523
Short-term investments 121,407 91,695
Accounts receivable, net 133,563 130,990
Inventory 258,616 228,732
Prepaid and other current assets 11,618 19,492
Total current assets 724,981 689,098
Property, plant and equipment, net 114 874
Long-term investments   1,275
Long-term inventory 77,615 163,620
Operating lease right-of-use asset 8,310 9,074
Other long-term assets 1,360 458
Intangible asset, net 19,304 21,780
TOTAL ASSETS 831,684 886,179
Current Liabilities:    
Accounts payable 52,762 64,602
Accrued expenses and other current liabilities 204,174 192,678
Current deferred revenue 2,341 2,199
Total current liabilities 259,277 259,479
Long-Term Liabilities:    
Long-term deferred revenue 2,509 13,147
Long-term operating lease liability 8,737 10,015
Other long-term liabilities 9,064 8,205
Total liabilities 279,587 290,846
Commitments and contingencies (Note 7)
Stockholders’ Equity:    
Common stock, GBP 0.50 par, unlimited authorized; 418,141,295 shares issued, 408,824,093 shares outstanding at December 31, 2023; 412,333,087 shares issued, 404,346,256 shares outstanding at December 31, 2022 302,756 299,002
Additional paid-in capital 1,899,456 1,885,352
Treasury stock; 9,317,202 shares at December 31, 2023; 7,986,831 shares at December 31, 2022 (63,752) (61,770)
Accumulated deficit (1,586,363) (1,527,251)
Total stockholders’ equity 552,097 595,333
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 831,684 $ 886,179